Pet/mri (axumin) study of men with highly suspicious mri lesions that showed no clinically signiciant prostate cancer following mri fusion targeted biopsy
Condition: Prostate Cancer Intervention: Diagnostic Test: Fluciclovine PET/MRI Sponsor: New York University School of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials